Point72 Asset Management »

Xilio Therapeutics shares owned by Point72 Asset Management

Quarter-by-quarter ownership of Xilio Therapeutics (XLO) shares owned by Point72 Asset Management from 13F filings

Historical chart of Point72 Asset Management investment in Xilio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Xilio Therapeutics held by Point72 Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xilio Therapeutics by Point72 Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.6M 4.0M 0.64

More positions owned by Point72 Asset Management

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Amazon (AMZN)
Broadcom (AVGO)
Arista Networks Com Shs (ANET)
Microsoft Corporation (MSFT)
Credo Technology Group Holdi Ordinary Shares (CRDO)
Asml Holding N V N Y Registry Shs (ASML)
Spotify Technology S A SHS (SPOT)
Sea Sponsord Ads (SE)
Biogen Idec (BIIB)
Equinix (EQIX)
Coherent Corp (COHR)

View all positions for Point72 Asset Management

Top funds holding Xilio Therapeutics

Gilead Sciences
Bain Capital Life Sciences Investors
Frazier Life Sciences Management
Point72 Asset Management
Stempoint Capital
Merck & Co
Takeda Pharmaceutical
Vanguard Group
Empery Asset Management
Ghisallo Capital Management
AJU IB Investment
FMR
Renaissance Technologies
Geode Capital Management
Balyasny Asset Management

View all funds holding Xilio Therapeutics